The Agitation Workouts take longer to recover from
Liu JT, Yeh HM, Liu SY, Chen KT
Glucose Signaling and Endocrine Pathways AOD 9604 has been investigated in laboratory models assessing glucose metabolism and endocrine signaling
BPC-157 works locally it modulates your nitric oxide system, ramps up growth factors (VEGF, EGF, TGF-beta), and gets repair cells moving to the injury via the FAK-paxillin pathway
If you develop a vitamin B-12 deficiency, intramuscular or subcutaneous injections may be necessary
Phase Weeks 1-2 Draw volume 7.5 units (0.075 mL) Total blend delivered ~2.0 mg total blend GHK-Cu ~1.25 mg KPV ~250 mcg BPC-157 ~250 mcg TB-500 ~250 mcg Phase Weeks 3-4 Draw volume 15 units (0.15 mL) Total blend delivered ~4.0 mg total blend GHK-Cu ~2.5 mg KPV ~500 mcg BPC-157 ~500 mcg TB-500 ~500 mcg Phase Weeks 5-8 Draw volume 22.5 units (0.225 mL) Total blend delivered ~6.0 mg total blend GHK-Cu ~3.75 mg KPV ~750 mcg BPC-157 ~750 mcg TB-500 ~750 mcg Phase Weeks 9-12 (taper) Draw volume 15 units (0.15 mL) Total blend delivered ~4.0 mg total blend GHK-Cu ~2.5 mg KPV ~500 mcg BPC-157 ~500 mcg TB-500 ~500 mcg Blend ratio 50 / 10 / 10 / 10 mg GHK-Cu dominant Select a draw volume from the titration table above to see the approximate amount of each peptide delivered